bendamustine hydrochloride has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giles, FJ | 1 |
| Gattermann, N; Germing, U; Haas, R; Hartmann, J; Knipp, S; Strupp, C | 1 |
2 other study(ies) available for bendamustine hydrochloride and Leukemia, Myeloid
| Article | Year |
|---|---|
Bendamustine and cloretazine: alkylators with sharply contrasting activity in AML.
Topics: Acute Disease; Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hydrazines; Leukemia, Myeloid; Mutagenesis; Nitrogen Mustard Compounds; Sulfonamides | 2007 |
A pilot study of bendamustine in elderly patients with high-risk MDS and AML.
Topics: Acute Disease; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Pilot Projects | 2007 |